HSD103 Evolution 2019-2020 of Immune Checkpoint Inhibitors (ICI) Administration in Hospitalization at Home (HAH) for Cancer Patients in Fran Descriptive Analysis From the French Public Health Insurance Database (PMSI)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1446
https://www.valueinhealthjournal.com/article/S1098-3015(22)03651-8/fulltext
Title :
HSD103 Evolution 2019-2020 of Immune Checkpoint Inhibitors (ICI) Administration in Hospitalization at Home (HAH) for Cancer Patients in Fran Descriptive Analysis From the French Public Health Insurance Database (PMSI)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03651-8&doi=10.1016/j.jval.2022.09.1446
First page :
Section Title :
Open access? :
No
Section Order :
10994